Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Beer compound could help fend off Alzheimer's and Parkinson's diseases

  • Novel radioguided brain surgery technique could help pinpoint cancerous tissue

  • Concentrating on word sounds helps reading instruction and intervention

  • Molecular alterations in head and neck cancers uncovered by study

  • Why upper motor neurons degenerate in ALS

  • Cell imaging gets colorful

  • New theoretical framework for future studies of resilience

  • Playing with puzzles, blocks may build children's spatial skills

  • Intracranial stimulation proved efficient in the recovery of learning and memory in rats

  • New biological evidence reveals link between brain inflammation and major depression

  •